Clinical trials: Heart Failure With Reduced Ejection Fraction, HFrEF
- Condition Heart Failure With Reduced Ejection Fraction, HFrEF
- Funder type Industry (pharma, biotech, devices)
Chronic Heart Failure With Reduced Ejection Fraction
Omecamtiv Mecarbil Post-trial Access Study
The primary objective of this study is to provide access to omecamtiv mecarbil for participants who have completed GALACTIC-HF 20110203.
- Trial name
- NCT04464525
- Testing
- Omecamtiv mecarbil
- Sponsor
- Cytokinetics